Conscious analgesia with oxycodone improves the efficacy and safety in patients at high risk of aspiration during gastroscopy: a randomized double-blind trial

在胃镜检查中,对于有高误吸风险的患者,使用羟考酮进行意识镇痛可提高疗效和安全性:一项随机双盲试验

阅读:2

Abstract

BACKGROUND: For the patients at high-risk of aspiration, general anesthesia may increase the risk of aspiration, while local pharyngeal anesthesia may cause extreme discomfort and even failure of gastroscopy. In this study, we tested the efficacy and safety of conscious analgesia with oxycodone in these patients. METHODS: In this prospective, randomized, double-blind, parallel-controlled trial, the patients were randomly assigned to either the oxycodone group (group O) or the 0.9% saline group (group C). Before the gastroscope insertion, group O received oxycodone (0.05 mg/kg), while group C received an equivalent volume of 0.9% normal saline. In cases where initial gastroscope insertion failed, a rescue dose of propofol (0.5 mg/kg) was administered. The success rate of the first gastroscopy placement, the number of gastroscope insertion and rescue propofol, total consumption of propofol, duration of the procedure, patient tolerance, perioperative adverse events, the satisfaction of patients and endoscopists were compared. RESULTS: A total of 175 patients were recruited, and no patient experienced aspiration. The success rate of initial gastroscope insertion and the satisfaction of patients and endoscopists in group O were higher than those in group C (P < 0.001). The number of gastroscope insertion, rescue times and total consumption of propofol, duration of the procedure, the behavioral pain scale non-intubated (BPS-NI) at the time of initial gastroscope insertion, intraoperative retching, limb movement, and tachycardia in group O were significantly lower than those in group C (all P < 0.001). CONCLUSION: Conscious analgesia with oxycodone could help some patients at high risk of aspiration to complete the gastroscopy effectively and safely. TRIAL REGISTRATION: Registered in the Chinese Clinical Trial Registry (ChiCTR-2100053142 ) on November 13, 2021. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-025-03595-w.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。